Logo
Logo
LOGIN
SUBSCRIBE
EXPERIENCE PSILOCYBIN
SHOP MERCH
WORK WITH US
ARCHIVE
Logo
Logo

BACK ISSUES

This Week in Psychedelics

Our flagship Wednesday newsletter breaks down the latest and greatest updates across psychedelic research, policy, and business. It’s serious psychedelic news, delivered with personality… and memes. Gotta have the memes.

READ MORE

Ask a Guide Anything

Every Friday, we source one burning question directly from you, dear readers, and pitch it to our network of vetted psychedelic practitioners. There are no stupid questions, but we do love a good brain buster.

READ MORE

Psychonaut POV

On Sundays, we spotlight a luminary in the psychedelic field with a feature interview. It could be a clinician, a researcher, an entrepreneur, an advocate… variety is the spice of life. These pioneers don’t all always agree, and that’s part of what makes the series great.

READ MORE

ARCHIVE

🫠 Psychonaut POV

Sep 15, 2024

🫠 Psychonaut POV

[5-min read] Q&A with April Pride, Creative Entrepreneur

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Sep 11, 2024

🫠 This Week in Psychedelics

[5-min read] AI-powered psychedelic company is approved to launch human trials.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Sep 8, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Amánda Efthimiou, Consultant & Coach

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Sep 4, 2024

🫠 This Week in Psychedelics

[5-min read] FDA and DEA schedule public hearings on psychedelics.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Sep 1, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Stephanie Karzon Abrams, Neuropharmacologist & Founder

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Aug 28, 2024

🫠 This Week in Psychedelics

[5-min read] MindBio shares durability data from LSD microdosing study.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Aug 25, 2024

🫠 Psychonaut POV

[6-min read] Q&A with Carlos Tanner, Curandero & Founder

Henry Winslow
Henry Winslow
 🫠 This Week in Psychedelics

Aug 21, 2024

🫠 This Week in Psychedelics

[5-min read] Rick Doblin steps down from Lykos Therapeutics.

Henry Winslow
Henry Winslow
 🫠 Psychonaut POV

Aug 18, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Kevin Cannella, Cofounder & Director

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Aug 14, 2024

🫠 This Week in Psychedelics

[5-min read] FDA rejects Lykos's application for MDMA-assisted therapy.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Aug 11, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Acacea Lewis, Researcher & Historian

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Aug 7, 2024

🫠 This Week in Psychedelics

[5-min read] New studies suggest psychedelics could treat diabetes and obesity.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Aug 4, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Daniel Carcillo, NHL Champion & Entrepreneur

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Jul 31, 2024

🫠 This Week in Psychedelics

[5-min read] J&J submits Spravato to the FDA for expanded approval.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Jul 28, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Jon Clark, Posture Therapist & Author

Henry Winslow
Henry Winslow
LOAD MORE

Stay ahead of the psychedelic movement. Industry news and practical wisdom, with a side of spicy memes. 🫠

I consent to receive newsletters via email. Terms of use and Privacy policy.

EXPERIENCE PSILOCYBIN

SHOP MERCH

work with us

archive

Β© 2026 Tricycle Day.
beehiivPowered by beehiiv